Alcoholic Hepatitis Treatment Market Report 2026

Alcoholic Hepatitis Treatment Market Overview

• Alcoholic Hepatitis Treatment market size has reached to $3.43 billion in 2025 • Expected to grow to $5.26 billion in 2030 at a compound annual growth rate (CAGR) of 9.1% • Growth Driver: Rising Incidence Of Alcohol-Induced Liver Diseases Is A Catalyst For Growth In The Alcoholic Hepatitis Treatment Market • Market Trend: Innovative Immunoassays For Alcoholic Hepatitis Treatment Market Through A Focus On Detecting Hepatitis B E Antigen (HBEAG) For Enhanced Monitoring And Diagnosis • North America was the largest region and fastest growing region.

What Is Covered Under Alcoholic Hepatitis Treatment Market?

Alcoholic hepatitis treatment refers to treatments provided for giving up alcohol and receiving treatments to lessen the symptoms of liver damage. Alcoholic hepatitis is treated in part by abstaining from alcohol and receiving therapy to minimize the warning signs and symptoms of liver damage. The main types of treatment for alcoholic hepatitis are drug treatment and stem cell therapy. Drug treatment refers to a medication other than food that is used to stop, spot, treat, or lessen a disease's or abnormal condition's symptoms. The drug classes are corticosteroids, hemorheologic agents, monoclonal antibodies, anabolic steroids, and others, which are administered through oral and injectable routes. These are used by hospitals, clinics, and private treatment centers.

What Is The Alcoholic Hepatitis Treatment Market Growth Forecast?

The alcoholic hepatitis treatment market size is expected to see strong growth in the next few years. It will grow to $5.26 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to advancement in regenerative medicine and stem cell therapies, growing investment in private treatment centers, rising adoption of personalized medicine approaches, increasing government initiatives for liver disease management, development of novel biologics for liver protection. Major trends in the forecast period include rising adoption of corticosteroid and hemorheologic therapies, increasing use of stem cell therapy for liver regeneration, expansion of private treatment centers and clinics, growing focus on personalized treatment plans for alcoholic hepatitis, enhanced awareness and early diagnosis programs.

Global Alcoholic Hepatitis Treatment Market Segmentation

1) By Treatment Type: Drug Therapy, Supportive And Nutritional Therapy 2) By Route Of Administration: Oral, Injectable 3) By Severity Of Disease: Mild Alcoholic Hepatitis, Moderate Alcoholic Hepatitis, Severe Alcoholic Hepatitis 4) By End-User: Hospitals, Specialty Clinics, Rehabilitation And De-Addiction Centers Subsegments: 1) By Drug Therapy: Corticosteroid Therapy, Hemorheologic Therapy, Immunomodulatory And Anti-Inflammatory Therapy, Antioxidant And Hepatoprotective Therapy, Adjunctive Pharmacological Therapy 2) By Supportive And Nutritional Therapy: Alcohol Abstinence And Detoxification Support, Nutritional Supplementation (Protein Vitamins And Minerals), Enteral Nutrition Support, Electrolyte And Fluid Management, Management Of Alcohol Withdrawal Symptoms

What Is The Driver Of The Alcoholic Hepatitis Treatment Market?

The increased prevalence of liver diseases caused by alcohol consumption is expected to propel the growth of the alcoholic hepatitis treatment market going forward. Alcoholic liver disease is the result of the liver's function being damaged. The liver performs numerous bodily processes, such as cleansing the blood and generating bile to aid digestion. Alcoholic hepatitis treatment is used to treat some patients with this condition's liver inflammation. It may be required to receive therapy in a hospital for those with severe alcoholic hepatitis. For instance, in April 2024, according to the data published by the Office for Health Improvement and Disparities, a UK-based government unit, premature deaths from liver disease in 2022 totaled 10,593, with 6,664 occurring among males and 3,929 among females, while the financial year ending in 2023 saw 85,665 hospital admissions for liver disease in England, equating to a rate of 155.2 per 100,000 population, which included 27,085 admissions specifically for alcoholic liver disease, corresponding to a rate of 49.4 per 100,000 population. Therefore, the increased prevalence of liver diseases caused by alcohol is driving the growth of the alcoholic hepatitis treatment industry.

Key Players In The Global Alcoholic Hepatitis Treatment Market

Major companies operating in the alcoholic hepatitis treatment market are Mallinckrodt Pharmaceuticals, Intercept Pharmaceuticals Inc., DURECT Corporation, BioVie Inc., Conatus Pharmaceuticals Inc., AbbVie Inc., Gilead Sciences Inc., Pfizer Inc., Merck And Co Inc., Bristol Myers Squibb Company, Johnson And Johnson, Sanofi SA, Novartis AG, Takeda Pharmaceutical Company Limited, Bayer AG, Boehringer Ingelheim International GmbH, Madrigal Pharmaceuticals Inc., Genfit SA, CymaBay Therapeutics Inc., Zydus Cadila, Dr Reddys Laboratories Ltd

Global Alcoholic Hepatitis Treatment Market Trends and Insights

Major companies operating in the alcoholic hepatitis treatment market are directing their efforts toward product development such as immunoassays to drive revenues in their market. Immunoassays are a type of biochemical test that uses the specific binding of antibodies to antigens to detect and measure the presence or concentration of a target molecule (analyte) in a sample. For instance, in November 2023, F. Hoffmann-La Roche Ltd., a Switzerland-based healthcare company launched Elecsys HBeAg quant. This immunoassay measures the amount of hepatitis B e antigen (HBeAg) in human serum and plasma in both qualitative and quantitative forms. It can serve as a predictor of both chronic active hepatitis and an early indication of acute hepatitis B infection. The test can aid in the diagnosis and follow-up of individuals with hepatitis B virus infection when paired with additional laboratory findings and clinical data. The Elecsys HBeAg quant may be used on Roche's Cobas e analyzers and is designed to be utilized with samples from patients who have previously tested positive as well as those whose HBeAg status is unknown.

What Are Latest Mergers And Acquisitions In The Alcoholic Hepatitis Treatment Market?

In September 2025, Bausch Health Companies Inc., a Canada-based provider of pharmaceuticals, medical devices, and diversified healthcare products, acquired DURECT Corporation for approximately $63 million. With this acquisition, Bausch Health aims to strengthen and expand its late-stage hepatology portfolio by adding larsucosterol, a Breakthrough Therapy-designated drug candidate for alcohol-associated hepatitis, to advance treatment options in an area with significant unmet medical need. DURECT Corporation is a US-based biopharmaceutical company that develops epigenetic and inflammation-targeted therapeutics, including its lead candidate larsucosterol for severe alcohol-associated hepatitis.

Regional Outlook

North America was the largest region in the alcoholic hepatitis treatment market in 2025. It is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Alcoholic Hepatitis Treatment Market?

The alcoholic hepatitis treatment market consists of revenues earned by entities by providing infection surveillance, ulcer prophylaxis, and liver transplantation. The market value includes the value of related goods sold by the service provider or included within the service offering. The alcoholic hepatitis treatment market also includes sales of anti-inflammatory medication such as steroids, pentoxifylline, and glucocorticoids. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Alcoholic Hepatitis Treatment Market Report 2026?

The alcoholic hepatitis treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the alcoholic hepatitis treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.